GB955683A - Pharmaceutical cobalamin compositions - Google Patents

Pharmaceutical cobalamin compositions

Info

Publication number
GB955683A
GB955683A GB29466/60A GB2946660A GB955683A GB 955683 A GB955683 A GB 955683A GB 29466/60 A GB29466/60 A GB 29466/60A GB 2946660 A GB2946660 A GB 2946660A GB 955683 A GB955683 A GB 955683A
Authority
GB
United Kingdom
Prior art keywords
cobalamin
acid
amino acid
mixtures
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29466/60A
Inventor
John Godfrey Heathcote
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Distillers Co Yeast Ltd
Distillers Co Ltd
Original Assignee
Distillers Co Yeast Ltd
Distillers Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Distillers Co Yeast Ltd, Distillers Co Ltd filed Critical Distillers Co Yeast Ltd
Priority to GB29466/60A priority Critical patent/GB955683A/en
Priority to FR871480A priority patent/FR1350M/en
Publication of GB955683A publication Critical patent/GB955683A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical preparation for oral or parenteral administration in the treatment of pernicious anaemia comprises at least one cobalamin and at least one L-amino acid or mixed DL-amino acid. Any physiologically active form of cobalamin may be used, e.g. cyanocobalamin, hydroxocobalamin or nitritocobalamin. Specified L-amino acids are glutamic acid, aspartic acid, glycine, valine, proline, arginine, cysteine, serine, alanine, leucine, isoleucine, phenylalanine, lysine, histidine, threonine, tryptophane, tyosine, methionine and mixtures thereof; mixtures of glutamic acid and aspartic acid being preferred. The weight for weight ratio of amino acid to cobalamin is between 1 : 1 and 20 : 1. The preparation may be used orally, e.g. in aqueous solution or as tablets; or parenterally, e.g. in sterile water.
GB29466/60A 1960-08-26 1960-08-26 Pharmaceutical cobalamin compositions Expired GB955683A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB29466/60A GB955683A (en) 1960-08-26 1960-08-26 Pharmaceutical cobalamin compositions
FR871480A FR1350M (en) 1960-08-26 1961-08-24 Improved cobalamin preparations.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29466/60A GB955683A (en) 1960-08-26 1960-08-26 Pharmaceutical cobalamin compositions

Publications (1)

Publication Number Publication Date
GB955683A true GB955683A (en) 1964-04-15

Family

ID=10291996

Family Applications (1)

Application Number Title Priority Date Filing Date
GB29466/60A Expired GB955683A (en) 1960-08-26 1960-08-26 Pharmaceutical cobalamin compositions

Country Status (2)

Country Link
FR (1) FR1350M (en)
GB (1) GB955683A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231768A1 (en) * 1986-01-13 1987-08-12 Morinaga Milk Industry Co., Ltd. A composition of amino acids
US5767123A (en) * 1994-11-17 1998-06-16 Tanabe Seiyaku Co., Ltd. Total parenteral nutrition solution containing water-soluble vitamin B

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231768A1 (en) * 1986-01-13 1987-08-12 Morinaga Milk Industry Co., Ltd. A composition of amino acids
US5767123A (en) * 1994-11-17 1998-06-16 Tanabe Seiyaku Co., Ltd. Total parenteral nutrition solution containing water-soluble vitamin B

Also Published As

Publication number Publication date
FR1350M (en) 1962-06-12

Similar Documents

Publication Publication Date Title
TR199901132T2 (en) To inhibit the release and/or synthesis of β-amyloid peptide using N-(aryl/heteoaryl) amino acid derivatives, pharmaceutical compositions containing them, and such compounds for methods.
GB1399888A (en) Injectable amino acid composition
MX9703642A (en) Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein.
SE9002500L (en) PHARMACEUTICAL, NAC CONTAINING COMPOSITION FOR ORAL ADMINISTRATION
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
JPH0773479B2 (en) Nutrient composition
ATE69164T1 (en) MEDICATIONS FOR THE TREATMENT OF URAEMIA.
PT90308A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING AZELASTIN WITH CONTROLLED LIBERTACAOUS ACTIVE SUBSTANCE
GB955683A (en) Pharmaceutical cobalamin compositions
KR840008279A (en) Atomization Method of Amino Acid-Containing Fat Emulsion
ES2072244T1 (en) REACTION COMPOUNDS AND PRODUCTS OF AMADORI, PROCEDURE FOR THEIR MANUFACTURE AND USE THEREOF.
GB1034358A (en) Body-protein-biosynthesis promoting composition
JPS5781409A (en) External plaster
AR009425A1 (en) USE OF CREATINE IN THE PREPARATION OF A DRUG FOR THE TREATMENT OF HEART AND / OR RESPIRATORY INSUFFICIENCIES
HU9602024D0 (en) Pharmaceutical composition containing aminoacid using external
US3146166A (en) Cobalamin and amino acid compositions
GB900115A (en) Improvements in or relating to trypsin solutions
GB944428A (en) Cobalamin derivatives
KR870010079A (en) Tripeptide with immunostimulatory activity
GB952812A (en) Tetracycline compositions
KR870008581A (en) Pharmaceutical Formulations of Stable and Injectable 1,4-Dihydroxy-5,8-bis [2- (2-hydroxyethylamino) ethylamino] anthraquinone, dihydrochloride
DK115789A (en) PHARMACEUTICAL AGENT FOR ORAL ADMINISTRATION, ISRAEL FOR IRON AND MAGNESIUM SUBSTITUTION TAPI
DE3879837D1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CERBERAL PSYCHO-ORGANIC SYNDROME.
CY1106169T1 (en) COMPOSITION OF PROPIONYL L-CARNITINE AND GLYCINE FOR THE PREVENTION AND/OR TREATMENT OF CYTOTOXIC EFFECTS INDUCED BY THE USE OF IMMUNOSUPPRESSANT AGENTS
JPS5668374A (en) Food composition for hepatic insufficiency